![]() |
Alzheimer's Disease |
Free Subscription
13 Alzheimers Dement |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
"Real-world" eligibility for anti-amyloid treatment in a tertiary memory clinic
setting.
Alzheimers Dement. 2025;21:e70375.
PubMed
Abstract available
White matter trajectories in Down syndrome and Alzheimer's disease: Insights from
diffusion tensor-based morphometry.
Alzheimers Dement. 2025;21:e70382.
PubMed
Abstract available
Impact of APOE4-related dementia risk in underrepresented groups from the All of
Us research program.
Alzheimers Dement. 2025;21:e70245.
PubMed
Abstract available
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the
identification of Alzheimer's disease: A consecutive mixed memory clinic cohort
study.
Alzheimers Dement. 2025;21:e70315.
PubMed
Abstract available
Disease-specific neuropathological alterations of the locus coeruleus in
Alzheimer's disease, Down syndrome, and Parkinson's disease.
Alzheimers Dement. 2025;21:e70262.
PubMed
Abstract available
Presynaptic loss and axonal degeneration synergistically correlate with
longitudinal neurodegeneration and cognitive decline.
Alzheimers Dement. 2025;21:e70080.
PubMed
Abstract available
Associations between Abeta deposition and neurometabolic alterations in Alzheimer's
disease: Insights from hybrid 3D MRSI-PET imaging.
Alzheimers Dement. 2025;21:e70332.
PubMed
Abstract available
GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and
dementia.
Alzheimers Dement. 2025;21:e70329.
PubMed
Abstract available
Epigenome-wide association study of cerebrospinal fluid-based biomarkers of
Alzheimer's disease in cognitively normal individuals.
Alzheimers Dement. 2025;21:e70318.
PubMed
Abstract available
Integrating plasma p-tau217 and digital cognitive assessments for early detection
in Alzheimer's disease.
Alzheimers Dement. 2025;21:e70355.
PubMed
Abstract available
Cerebrospinal fluid and brain positron emission tomography measures of synaptic
vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease.
Alzheimers Dement. 2025;21:e70344.
PubMed
Abstract available
Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early
Alzheimer's disease.
Alzheimers Dement. 2025;21:e70330.
PubMed
Abstract available
Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy
assays.
Alzheimers Dement. 2025;21:e70195.
PubMed
Abstract available
The Association of Alzheimer's Disease Genetic Risk with Social Connectedness in
Middle- And Older-Ages.
Am J Epidemiol. 2025 Jun 11:kwaf122. doi: 10.1093.
PubMed
Abstract available
Burden of risk factors attributable to Alzheimer's disease and other dementia and
its relationship with the Socio-Demographic index in Asia.
BMC Neurol. 2025;25:247.
PubMed
Abstract available
Early proteasome downregulation and dysfunction drive proteostasis failure in
Alzheimer's disease.
Brain. 2025 Jun 9:awaf222. doi: 10.1093.
PubMed
Abstract available
Bridging the gap between structural and metabolic neuroimaging via MRI-to-PET
synthesis: A tri-attention enhanced GAN approach.
Brain Res. 2025;1862:149691.
PubMed
Abstract available
Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease:
mechanisms and therapeutic potential.
Brain Res. 2025 Jun 9:149776. doi: 10.1016/j.brainres.2025.149776.
PubMed
Abstract available
Exploring the Neuroprotective Potential of Polyphenolic Compounds in Mitigating
Quinolinic Acid-Induced Neurotoxicity in Alzheimer's Disease.
Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050383383250529100802.
PubMed
Abstract available
Assessment of the Inhibition of AChE and BChE by Carthamus caeruleus Essential
Oil and Carline Oxide: Neuroprotective Effects and In Vivo Toxicity Assessment
for the Management of Alzheimer's Disease.
Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050383227250529072253.
PubMed
Abstract available
Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta and
Gamma Secretases.
Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050380899250602042028.
PubMed
Abstract available
Advance Nanotechnology-Based Drug Delivery Systems for Alzheimer's Disease:
Advancements and Future Perspectives.
Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050380959250530112247.
PubMed
Abstract available
Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An
Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from
Normal Aging.
Dement Geriatr Cogn Disord. 2025 Jun 11:1-19. doi: 10.1159/000546451.
PubMed
Abstract available
Circulating short chain fatty acids in Alzheimer's disease: A cross-sectional
observational study.
J Alzheimers Dis. 2025 Jun 12:13872877251337773. doi: 10.1177/13872877251337773.
PubMed
Abstract available
Effect of comprehensive geriatric assessment intervention on serum S100beta levels
and clinical outcomes in patients with Alzheimer's disease.
J Alzheimers Dis. 2025 Jun 10:13872877251344544. doi: 10.1177/13872877251344544.
PubMed
Abstract available
Implementation of Lecanemab for Alzheimer's Disease Within the Veterans Health
Administration: Facilitators and Barriers.
J Am Geriatr Soc. 2025 Jun 11. doi: 10.1111/jgs.19577.
PubMed
Abstract available
Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral
Vestibular Disorders: A Longitudinal Study of 140,726 Participants.
J Clin Psychiatry. 2025;86:24m15699.
PubMed
Abstract available
What to Know About the First FDA-Cleared Blood Test for Alzheimer Biomarkers.
JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.9013.
PubMed
Protective exercise responses in the dentate gyrus of Alzheimer's disease mouse
model revealed with single-nucleus RNA-sequencing.
Nat Neurosci. 2025 Jun 12. doi: 10.1038/s41593-025-01971.
PubMed
Abstract available
Alzheimer disease in Down syndrome linked to APOE.
Nat Rev Neurol. 2025 Jun 9. doi: 10.1038/s41582-025-01110.
PubMed
Biological age acceleration in Alzheimer's disease modulates relative cortical to
medial temporal lobe neurodegeneration.
Neurobiol Aging. 2025;153:21-29.
PubMed
Abstract available
The Neuroprotective Impact of Agomelatine in Preserving Brain Tissue Molecular
Structure Against Alzheimer's Disease Etiology.
Neurochem Res. 2025;50:189.
PubMed
Abstract available
Exploration of Asparagus racemosus Willd for Alzheimer's Disease Through
Integrated Metabolomics and Network Pharmacology Analyses Targeting BACE1
Protein.
Neurochem Res. 2025;50:190.
PubMed
Abstract available
Selective Vulnerability of Hippocampi for Nitric Oxide Synthases in Alzheimer's
Disease Pathology and Cognitive Abilities.
Neurochem Res. 2025;50:197.
PubMed
Abstract available
Expression of concern: "Hydrogen-rich saline reduces oxidative stress and
inflammation by inhibit of JNK and NF-kappaB activation in a rat model of
amyloid-beta-induced Alzheimer's disease" [NEUROSCI LETT, Volume 491 (2011)
127-132].
Neurosci Lett. 2025;859-861:138254.
PubMed
Comparisons of metabolites and gut microbiota profiles for both young and
middle-aged APPSwe/PS1De9 mice.
Neuroscience. 2025;577:54-63.
PubMed
Abstract available
An ensemble-based 3D residual network for the classification of Alzheimer's
disease.
PLoS One. 2025;20:e0324520.
PubMed
Abstract available
Atherosclerosis is associated with amyloid and tau pathology via blood-brain
barrier dysfunction in the hippocampus of aged human brains.
PLoS One. 2025;20:e0324652.
PubMed
Abstract available
Thank you for your interest in scientific medicine.